Clinical Trial Update: Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD) [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 efficacy and safety study for second-line treatment in patients with hypertension associated with autosomal dominant polycyst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease
• Hypertension

Snippet

Sponsor: Ministry of Health, Labour and Welfare, Japan | Conditions: Kidney, Polycystic, Autosomal Dominant | Phase 2 | Status: UNKNOWN